See also this year's filing and all EDGAR filings for this company.
PDF Report 0001517681_2019_Propanc_Biopharma_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001517681')"} |
Graph
Absolute values for 0001517681, Propanc Biopharma Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 60,890 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 8,277 |
| 3 | remainder_Assets | 2,220 |
| 4 | LiabilitiesCurrent | 6,823,307 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 30,521 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,103,684 |
| 9 | ResearchAndDevelopmentExpense | 1,825,728 |
| 10 | remainder_Expenses | -179,306 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -3,258,528 |
| 13 | remainder_ComprehensiveNetIncome | 499,678 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 71,387 |
| 1 | Liabilities | 6,823,307 |
| 2 | Expenses | 3,780,627 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -6,751,920 |
| 5 | NetIncome | -7,039,155 |
| 6 | ComprehensiveNetIncome | -6,789,316 |
| 7 | BaseVar | 7,216,764 |
| 8 | EconomicCapitalRatio | -5.34 |
Edgar->Model Mapping
Feature Distribution
Change over Time
